Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Radiation dosimetry of 82Rb in humans under pharmacologic stress.

Senthamizhchelvan S, Bravo PE, Lodge MA, Merrill J, Bengel FM, Sgouros G.

J Nucl Med. 2011 Mar;52(3):485-91. doi: 10.2967/jnumed.110.083477. Epub 2011 Feb 14.

2.

Proposed revision to the radiation dosimetry of 82Rb.

Stabin MG.

Health Phys. 2010 Dec;99(6):811-3. doi: 10.1097/HP.0b013e3181e47b33.

PMID:
21068600
3.

Human biodistribution and radiation dosimetry of 82Rb.

Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, Sgouros G, Bengel FM.

J Nucl Med. 2010 Oct;51(10):1592-9. doi: 10.2967/jnumed.110.077669. Epub 2010 Sep 16.

4.

EANM Dosimetry Committee guidance document: good practice of clinical dosimetry reporting.

Lassmann M, Chiesa C, Flux G, Bardiès M; EANM Dosimetry Committee.

Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):192-200. doi: 10.1007/s00259-010-1549-3. Epub 2010 Aug 27.

PMID:
20799035
5.

Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging.

Bouchelouche K, Turkbey B, Choyke P, Capala J.

Curr Urol Rep. 2010 May;11(3):180-90. doi: 10.1007/s11934-010-0105-9. Review.

6.

The determination of patient dose from (18)F-FDG PET/CT examination.

Khamwan K, Krisanachinda A, Pasawang P.

Radiat Prot Dosimetry. 2010 Sep;141(1):50-5. doi: 10.1093/rpd/ncq140. Epub 2010 Apr 17.

PMID:
20400773
7.

New calculations for internal dosimetry of beta-emitting radiopharmaceuticals.

Zankl M, Petoussi-Henss N, Janzen T, Uusijärvi H, Schlattl H, Li WB, Giussani A, Hoeschen C.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):245-9. doi: 10.1093/rpd/ncq045. Epub 2010 Feb 18.

PMID:
20167794
8.

177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.

Garkavij M, Nickel M, Sjögreen-Gleisner K, Ljungberg M, Ohlsson T, Wingårdh K, Strand SE, Tennvall J.

Cancer. 2010 Feb 15;116(4 Suppl):1084-92. doi: 10.1002/cncr.24796.

9.

Biodistribution and radiation dosimetry of [(11)C]choline: a comparison between rat and human data.

Tolvanen T, Yli-Kerttula T, Ujula T, Autio A, Lehikoinen P, Minn H, Roivainen A.

Eur J Nucl Med Mol Imaging. 2010 May;37(5):874-83. doi: 10.1007/s00259-009-1346-z. Epub 2010 Jan 13.

PMID:
20069295
10.

Dosimetry of Pediatric PET/CT.

Fahey FH.

J Nucl Med. 2009 Sep;50(9):1483-91. doi: 10.2967/jnumed.108.054130. Epub 2009 Aug 18. Review.

11.

[Radiation exposure of patients during 68Ga-DOTATOC PET/CT examinations].

Hartmann H, Zöphel K, Freudenberg R, Oehme L, Andreeff M, Wunderlich G, Eisenhofer G, Kotzerke J.

Nuklearmedizin. 2009;48(5):201-7. doi: 10.3413/nukmed-0214. Epub 2009 Jul 28. German.

PMID:
19639164
12.

MIRD dose estimate report No. 20: radiation absorbed-dose estimates for 111In- and 90Y-ibritumomab tiuxetan.

Fisher DR, Shen S, Meredith RF.

J Nucl Med. 2009 Apr;50(4):644-52. doi: 10.2967/jnumed.108.057331. Epub 2009 Mar 16. Erratum in: J Nucl Med. 2012 Apr;53(4):646.

13.

MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature.

Bolch WE, Eckerman KF, Sgouros G, Thomas SR.

J Nucl Med. 2009 Mar;50(3):477-84. doi: 10.2967/jnumed.108.056036.

14.

Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.

O'Keefe GJ, Saunder TH, Ng S, Ackerman U, Tochon-Danguy HJ, Chan JG, Gong S, Dyrks T, Lindemann S, Holl G, Dinkelborg L, Villemagne V, Rowe CC.

J Nucl Med. 2009 Feb;50(2):309-15. doi: 10.2967/jnumed.108.055756. Epub 2009 Jan 21.

16.

Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

Gelfand MJ.

Pediatr Radiol. 2009 Feb;39 Suppl 1:S46-56. doi: 10.1007/s00247-008-1023-6. Epub 2008 Dec 16. Review.

PMID:
19083225
17.

Uncertainties in internal dose calculations for radiopharmaceuticals.

Stabin MG.

J Nucl Med. 2008 May;49(5):853-60. doi: 10.2967/jnumed.107.048132. Epub 2008 Apr 15.

18.
19.

68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors.

Pettinato C, Sarnelli A, Di Donna M, Civollani S, Nanni C, Montini G, Di Pierro D, Ferrari M, Marengo M, Bergamini C.

Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):72-9. Epub 2007 Sep 14.

PMID:
17874094
20.

Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain.

Lim R, Fahey FH, Drubach LA, Connolly LP, Treves ST.

J Pediatr Orthop. 2007 Apr-May;27(3):277-82.

PMID:
17414009

Supplemental Content

Support Center